The FDA Law Blog

JANUARY 18, 2024

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By Larry K. 53,688 (Aug. 53,767 (Aug. 21 U.S.C. §

FDA 69

FDA Controlled Substances Chemotherapy Compounding 69

The Checkup by Singlecare

MARCH 21, 2023

Cymbalta is a non-opioid medication and was actually originally labeled as an antidepressant , more specifically a serotonin /norepinephrine reuptake inhibitor (SNRI). It is a synthetic codeine analog; it is a weak agonist at mu opioid receptors, and it is a weak SNRI.

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

The Checkup by Singlecare

MAY 8, 2023

Tramadol has been available in the United States since 1995, but not until 2014 did it become a schedule IV controlled substance by the Food and Drug Administration (FDA) based on data suggesting abuse potential similar to other schedule IV opioids available at that time. What can I take in place of tramadol?

Controlled Substances 52

Controlled Substances Dosage Labelling FDA 52

The FDA Law Blog

MAY 5, 2024

Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. Whether the drug is an immediate precursor of a substance already controlled.

Controlled Substances 91

Controlled Substances FDA Chemotherapy Dosage 91